New trends in kidney tumor diagnostics (literature review)

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Renal cell carcinoma (RCC) is one of the most common oncourological diseases and ranks 10th among malignant neoplasms in the world and 3rd among malignant neoplasms of the genitourinary system (EAU Guidelines, 2017). According to B.P. Matveev (2011), over the past decades, there has been a tendency to increase RCC by 2–4% per year in all population groups. This is attributable to both a true increase in a number of oncourological patients and the improvement of modern diagnostic capabilities. However, despite a significant number of patients with early identified tumor process, the mortality rate from the disease remains high. The only effective method of treating RCC is surgery, which involves nephrectomy or resection of the kidney with the tumor, but in 68.1% of patients with localized and locally advanced forms of the disease, according to B.P. Matveev (2011), tumor process progresses after radical treatment at various times. High incidence rate, large number of relapses, variability of the course of the tumor process after surgery and the lack of a single prognostic system with high accuracy determine the relevance of the problem and indicate the need to create a prognostic panel of factors that can accurately predict the course of the disease after surgery for RCC. The objective of the review is to determine the diagnostic value of CT angiography and CT perfusion in optimizing surgical treatment tactics and assessing the functional capacity of the renal parenchyma in RCC. The search results in the PubMed, Medline, Web of Science scientific databases for the queries «renal parenchyma cancer», «diagnosis of kidney tumors» were analyzed. The review provides detailed consideration and illustration of prognostic factors for the course of the disease in locally advanced renal cancer and the diagnostic value of CT angiography and CT perfusion in determining tumor invasion of intrarenal vessels.

Conclusion. Despite the long history of studying renal parenchymal cancer, there are still no reliable data on the diagnosis of kidney tumors and various prognostic factors for the course of RCC, therefore, the article analyzes and collects the results of recent studies.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Alan Khasigov

North Ossetian State Medical Academy

Хат алмасуға жауапты Автор.
Email: alan_hasigov@mail.ru
ORCID iD: 0000-0003-1103-4532
Ресей, Vladikavkaz

V. Tebiev

North Ossetian State Medical Academy

Email: alan_hasigov@mail.ru
ORCID iD: 0009-0001-2173-8384
Ресей, Vladikavkaz

A. Timoshenkova

North Ossetian State Medical Academy

Email: alan_hasigov@mail.ru
Ресей, Vladikavkaz

Әдебиет тізімі

  1. EAU Guidelines. Edn. presented at the EAU Ann Congress Barcelona 2019.
  2. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) М., 2018. илл. 250 с. [Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2017 (morbidity and mortality) M., 2018. ill. 250 p. (In Russ.)].
  3. American Cancer Society. Cancer Facts & Figures 2019.Atlanta: American Cancer Society; 2019.
  4. Noone A.M., Howlader N., Krapcho M., Cronin K.A. (eds.), et al. SEER Cancer Statistics Review, 1975–2015, National Cancer Institute. Bethesda, MD, URL: https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
  5. Speed J.M., Trinh Q.-D., Choueiri T.K., et al. Recurrence in localized renal cell carcinoma: A systematic review of contemporary data. Curr Urol Rep. 2017;18:15.
  6. Paner G.P., Stadler W.M., Hansel D.E., et al: Updates in the eighth edition of the tumornodemetastasis staging classification for urologic cancers. Eur Urol. 2018;73:1–10.
  7. Amin M.B., Edge S.B., Greene F.L., et al (eds.). AJCC Cancer Staging Manual, 8th ed. New York, NY, Springer, 2017.
  8. Delahunt B., Kittelson J.M., McCredie M.R., et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer. 2002;94:658–64.
  9. Lau W.K., Cheville J.C., Blute M.L., et al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology. 2002;59:532–37.
  10. Minervini R., Minervini A., Fontana N., et al. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. BJU Int. 2000;86:199–202.
  11. Moch H., Gasser T., Amin M.B., et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604–14.
  12. Zisman A., Pantuck A.J., Dorey F., et al. Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol. 2002;20:1368–74.
  13. Meskawi M., Sun M., Trinh Q.D., et al: A review of integrated staging systems for renal cell carcinoma. Eur Urol. 2012;62:303–14.
  14. Poel H.G., Roukema J.A., Horenblas S., et al. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Ibid. 1999;35(3):197–203.
  15. Giberti C., Oneto F., Martorana G., et al. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol. 1997;31(1):40–8.
  16. Ficarra V., Schips L., Guille F., et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer. 2005;104:968–74.
  17. Masuda H., Kurita Y., Fukuta K., et al. Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma. Int J Urol. 1998;5:418–22.
  18. Sene A.P., Hunt L., McMahon R.F., Carroll R.N. Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol. 1992;70:125–34.
  19. Golimbu M., Joshi P., Sperber A., et al. Renal cell carcinoma: survival and prognostic factors. Urology. 1986;27:291–301.
  20. Thompson R.H., Leibovich B.C., Cheville J.C., et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005;174:1218–21.
  21. Zisman A., Wieder J., Pantuck A., et al. Renal cell carcinoma with tumor thrombus extension: biology, role of neрhrectomy and response to immunotherapy. J Urol. 2003;169(3):909–16.doi: 10.1097/01.ju.0000045706.35470.1e.
  22. Thompson R.H., Cheville J.C., Lohse C.M., et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 2005;104:53–60.
  23. Oyasu R. Renal cancer: histologic classification update. Int J Clin Oncol. 1998;3:125–30.
  24. Ficarra V., Righetti R., D’Amico A., et al. Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma. Oncology. 2001;61:10–5.
  25. Inoue T., Hashimura T., Iwamura H., et al. Multivariate analysis of prognostic determinants after surgery for renal cell carcinoma at Himeji National Hospital. Hinyokika Kiyo. 2000;46:229–34.
  26. Keegan, K.A., et al. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188:391.
  27. Griffiths D.F., Verghese A., Golash A., et al. Contribution of grade, vascular invasio outcome in clinically localized renal cell carcinoma Brit J Urol Int. 2002;90(1):26–31.
  28. Vogel C., Ziegelmuller B., Ljungberg B., et al. Imaging in Suspected Renal Cell Carcinoma: Systematic Review. Clin Genitourin Cancer. 2019;17(2):345–55. doi: 10.1016/j.clgc.2018.07.024.
  29. Corral de la Calle M.Б., Encinas de la Iglesia J., Martin Lopez M.R., et al. The radiologist’s role in the management of papillary renal cell carcinoma. Radiologia. 2017;1(16):3019–20.
  30. Рубцова Н.А., Гольбиц А.Б., Крянева Е.В. и др. Роль КТ-перфузии в диагностике солидных опухолей почек. Лучевая диагностика и терапия. 2021;12(2):70–8. [Rubtsova N.A., Golbitz A.B., Kryaneva E.V. et al. The role of CT perfusion in the diagnosis of solid renal tumors. Diagnostics Radiology and Radiotherapy. 2021;12(2):70–8. (In Russ.)].
  31. Ломоносова Е.В., Гольбиц А.Б., Рубцова Н.А. и др. Перфузионная компьютерная томография в диагностике заболеваний почек (обзор литературы). Медицинская визуализация. 2023;27(2):85–98. [Lomonosova E.V., Golbits A.B., Rubtsova N.A., et al. Application of perfusion computed tomography in renal diseases (review of literature). Medical Visualization. 2023;27(2):85–98. (In Russ.)]. doi: 10.24835/1607-0763-1220.
  32. Климачев И.В., Бобров И.П., Черданцева Т.М. Морфофункциональная характеристика тучноклеточной популяции в перитуморозной зоне рака почки. Материалы III Международной научно-практической конкурс-конференции студентов и молодых ученых «Морфологические пауки – фундаментальная основа медицины», посвящ. 100 летию проф. Т.Д. Никитиной. Новосибирск, 2018. С. 108–11. [Klimachev I.V., Bobrov I.P., Cherdantseva T.M. Morphofunctional characteristics of the mast cell population in the peritumorous zone of kidney cancer. Proceedings of the III International Scientific and Practical Competition-Conference of Students and Young Scientists «Morphological Spiders - the Fundamental Basis of Medicine», dedicated to the 100th anniversary of prof. T.D. Nikitina. Novosibirsk, 2018. P. 108–11. (In Russ.)].
  33. Климачев И.В., Бобров И.П., Черданцева Т.М. Исследование процессов ангиогенеза в перитуморозной зоне почечно-клеточного рака. Материалы III Международной научно-практической конкурс-конференции студентов и молодых ученых «Морфологические пауки – фундаментальная основа медицины», посвящ. 100-летию проф. Т.Д. Никитиной. Новосибирск, 2018. С. 111–14. [Klimachev I.V., Bobrov I.P., Cherdantseva T.M. Study of angiogenesis processes in the peritumorous zone of renal cell carcinoma. Proceedings of the III International Scientific and Practical Competition-Conference of Students and Young Scientists «Morphological Spiders - the Fundamental Basis of Medicine», dedicated to the 100th anniversary of prof. T.D. Nikitina. Novosibirsk, 2018. P. 111–14. (In Russ.)].

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2024